At a glance
ClinicalIndex Comparison RecordN/AActive· 1,164 enrolled
Drug / intervention
MitraClip G4 Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
In Brief
An observational study evaluating MitraClip G4 System for Mitral Valve Regurgitation and Mitral Regurgitation. Active but no longer recruiting, targeting 1,164 participants across 63 sites in 10 countries.
Detailed Summary
This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMitral Valve Regurgitation, Mitral Regurgitation
CountriesCanada, France, Germany, Israel, Italy, Japan, Netherlands, Saudi Arabia, Spain, United States
CollaboratorsAbbott
Timeline
N/AActive
202020212022202320242025202620272028
First PostedNov 2019
Enrollment StartJan 2020
Primary CompletionMay 2022
TodayJul 2026
Study CompletionMar 2028
First PostedNov 26, 2019
Enrollment StartJan 17, 2020
Primary CompletionMay 19, 2022
Study CompletionMar 1, 2028
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.6 years ago
Interventions
MitraClip G4 Systemdevice
Percutaneous mitral valve repair using the MitraClip G4 system.